1	Geriatric	_	_	JJ	_	_	_	_	_
2	syndrome	_	_	NN	_	_	_	_	_
3	refers	_	_	VBZ	_	_	_	_	_
4	to	_	_	TO	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	series	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	symptoms	_	_	NNS	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	observations	_	_	NNS	_	_	_	_	_
11	caused	_	_	VBN	_	_	_	_	_
12	by	_	_	IN	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	variety	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	factors	_	_	NNS	_	_	_	_	_
17	associated	_	_	VBN	_	_	_	_	_
18	with	_	_	IN	_	_	_	_	_
19	aging	_	_	NN	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	where	_	_	WRB	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	older	_	_	JJR	_	_	_	_	_
24	adults	_	_	NNS	_	_	_	_	_
25	show	_	_	VBP	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	treatment	_	_	NN	_	_	_	_	_
28	consciously	_	_	RB	_	_	_	_	_
29	or	_	_	CC	_	_	_	_	_
30	otherwise	_	_	RB	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	and	_	_	CC	_	_	_	_	_
33	long-term	_	_	JJ	_	_	_	_	_
34	care	_	_	NN	_	_	_	_	_
35	becomes	_	_	VBZ	_	_	_	_	_
36	important	_	_	JJ	_	_	_	_	_
37	at	_	_	IN	_	_	_	_	_
38	the	_	_	DT	_	_	_	_	_
39	same	_	_	JJ	_	_	_	_	_
40	time	_	_	NN	_	_	_	_	_
41	.	_	_	.	_	_	_	_	_


1	With	_	_	IN	_	_	_	_	_
2	respect	_	_	NN	_	_	_	_	_
3	to	_	_	TO	_	_	_	_	_
4	geriatric	_	_	JJ	_	_	_	_	_
5	syndrome	_	_	NN	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	often	_	_	RB	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	viewpoint	_	_	NN	_	_	_	_	_
10	involves	_	_	VBZ	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	purpose	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	sustaining	_	_	VBG	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	capability	_	_	NN	_	_	_	_	_
17	for	_	_	IN	_	_	_	_	_
18	activities	_	_	NNS	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	daily	_	_	JJ	_	_	_	_	_
21	living	_	_	NN	_	_	_	_	_
22	(	_	_	-LRB-	_	_	_	_	_
23	ADL	_	_	NNP	_	_	_	_	_
24	)	_	_	-RRB-	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	improving	_	_	VBG	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	quality	_	_	NN	_	_	_	_	_
29	of	_	_	IN	_	_	_	_	_
30	life	_	_	NN	_	_	_	_	_
31	(	_	_	-LRB-	_	_	_	_	_
32	QOL	_	_	NN	_	_	_	_	_
33	)	_	_	-RRB-	_	_	_	_	_
34	,	_	_	,	_	_	_	_	_
35	rather	_	_	RB	_	_	_	_	_
36	than	_	_	IN	_	_	_	_	_
37	just	_	_	RB	_	_	_	_	_
38	considering	_	_	VBG	_	_	_	_	_
39	the	_	_	DT	_	_	_	_	_
40	disease	_	_	NN	_	_	_	_	_
41	condition	_	_	NN	_	_	_	_	_
42	according	_	_	VBG	_	_	_	_	_
43	to	_	_	TO	_	_	_	_	_
44	the	_	_	DT	_	_	_	_	_
45	diagnostic	_	_	JJ	_	_	_	_	_
46	name	_	_	NN	_	_	_	_	_
47	.	_	_	.	_	_	_	_	_


1	Notably	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	there	_	_	EX	_	_	_	_	_
4	are	_	_	VBP	_	_	_	_	_
5	geriatric	_	_	JJ	_	_	_	_	_
6	syndrome	_	_	NN	_	_	_	_	_
7	symptoms	_	_	NNS	_	_	_	_	_
8	that	_	_	WDT	_	_	_	_	_
9	are	_	_	VBP	_	_	_	_	_
10	more	_	_	RBR	_	_	_	_	_
11	frequent	_	_	JJ	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	are	_	_	VBP	_	_	_	_	_
14	largely	_	_	RB	_	_	_	_	_
15	affected	_	_	VBN	_	_	_	_	_
16	by	_	_	IN	_	_	_	_	_
17	long-term	_	_	JJ	_	_	_	_	_
18	care	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	such	_	_	JJ	_	_	_	_	_
21	as	_	_	IN	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	disorders	_	_	NNS	_	_	_	_	_
24	associated	_	_	VBN	_	_	_	_	_
25	with	_	_	IN	_	_	_	_	_
26	mobility	_	_	NN	_	_	_	_	_
27	(	_	_	-LRB-	_	_	_	_	_
28	remain	_	_	VB	_	_	_	_	_
29	secluded	_	_	JJ	_	_	_	_	_
30	,	_	_	,	_	_	_	_	_
31	or	_	_	CC	_	_	_	_	_
32	bedridden	_	_	JJ	_	_	_	_	_
33	)	_	_	-RRB-	_	_	_	_	_
34	,	_	_	,	_	_	_	_	_
35	falls	_	_	NNS	_	_	_	_	_
36	,	_	_	,	_	_	_	_	_
37	incontinence	_	_	NN	_	_	_	_	_
38	,	_	_	,	_	_	_	_	_
39	and	_	_	CC	_	_	_	_	_
40	cognitive	_	_	JJ	_	_	_	_	_
41	impairment	_	_	NN	_	_	_	_	_
42	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	are	_	_	VBP	_	_	_	_	_
3	considered	_	_	VBN	_	_	_	_	_
4	issues	_	_	NNS	_	_	_	_	_
5	for	_	_	IN	_	_	_	_	_
6	which	_	_	WDT	_	_	_	_	_
7	early	_	_	JJ	_	_	_	_	_
8	measures	_	_	NNS	_	_	_	_	_
9	should	_	_	MD	_	_	_	_	_
10	be	_	_	VB	_	_	_	_	_
11	incorporated	_	_	VBN	_	_	_	_	_
12	into	_	_	IN	_	_	_	_	_
13	geriatric	_	_	JJ	_	_	_	_	_
14	treatment	_	_	NN	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	recent	_	_	JJ	_	_	_	_	_
3	years	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	measures	_	_	NNS	_	_	_	_	_
6	against	_	_	IN	_	_	_	_	_
7	frailty	_	_	NN	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	sarcopenia	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	which	_	_	WDT	_	_	_	_	_
12	elevate	_	_	VBP	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	risk	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	increasing	_	_	VBG	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	need	_	_	NN	_	_	_	_	_
19	for	_	_	IN	_	_	_	_	_
20	long-term	_	_	JJ	_	_	_	_	_
21	care	_	_	NN	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	are	_	_	VBP	_	_	_	_	_
24	being	_	_	VBG	_	_	_	_	_
25	considered	_	_	VBN	_	_	_	_	_
26	important	_	_	JJ	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	Frailty	_	_	NN	_	_	_	_	_
2	progresses	_	_	VBZ	_	_	_	_	_
3	as	_	_	IN	_	_	_	_	_
4	vulnerability	_	_	NN	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	stress	_	_	NN	_	_	_	_	_
7	increases	_	_	VBZ	_	_	_	_	_
8	due	_	_	JJ	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	declining	_	_	VBG	_	_	_	_	_
11	physiological	_	_	JJ	_	_	_	_	_
12	reserves	_	_	NNS	_	_	_	_	_
13	with	_	_	IN	_	_	_	_	_
14	aging	_	_	NN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	making	_	_	VBG	_	_	_	_	_
17	one	_	_	CD	_	_	_	_	_
18	prone	_	_	JJ	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	unhealthy	_	_	JJ	_	_	_	_	_
21	conditions	_	_	NNS	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	factor	_	_	NN	_	_	_	_	_
5	that	_	_	WDT	_	_	_	_	_
6	increases	_	_	VBZ	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	risk	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	falling	_	_	VBG	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	disabilities	_	_	NNS	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	activities	_	_	NNS	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	daily	_	_	JJ	_	_	_	_	_
17	living	_	_	NN	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	onset	_	_	NN	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	need	_	_	NN	_	_	_	_	_
23	for	_	_	IN	_	_	_	_	_
24	long-term	_	_	JJ	_	_	_	_	_
25	care	_	_	NN	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	and	_	_	CC	_	_	_	_	_
28	death	_	_	NN	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	Frailty	_	_	NN	_	_	_	_	_
2	as	_	_	IN	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	concept	_	_	NN	_	_	_	_	_
5	includes	_	_	VBZ	_	_	_	_	_
6	not	_	_	RB	_	_	_	_	_
7	only	_	_	RB	_	_	_	_	_
8	physical	_	_	JJ	_	_	_	_	_
9	problems	_	_	NNS	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	such	_	_	JJ	_	_	_	_	_
12	as	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	representative	_	_	JJ	_	_	_	_	_
15	decline	_	_	NN	_	_	_	_	_
16	in	_	_	IN	_	_	_	_	_
17	muscle	_	_	NN	_	_	_	_	_
18	strength	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	but	_	_	CC	_	_	_	_	_
21	also	_	_	RB	_	_	_	_	_
22	mental	_	_	JJ	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	physical	_	_	JJ	_	_	_	_	_
25	problems	_	_	NNS	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	such	_	_	JJ	_	_	_	_	_
28	as	_	_	IN	_	_	_	_	_
29	cognitive	_	_	JJ	_	_	_	_	_
30	impairment	_	_	NN	_	_	_	_	_
31	and	_	_	CC	_	_	_	_	_
32	depression	_	_	NN	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	also	_	_	RB	_	_	_	_	_
3	includes	_	_	VBZ	_	_	_	_	_
4	social	_	_	JJ	_	_	_	_	_
5	problems	_	_	NNS	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	such	_	_	JJ	_	_	_	_	_
8	as	_	_	IN	_	_	_	_	_
9	solitary	_	_	JJ	_	_	_	_	_
10	living	_	_	NN	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	economic	_	_	JJ	_	_	_	_	_
13	distress	_	_	NN	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	Accordingly	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	it	_	_	PRP	_	_	_	_	_
4	needs	_	_	VBZ	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	be	_	_	VB	_	_	_	_	_
7	considered	_	_	VBN	_	_	_	_	_
8	comprehensively	_	_	RB	_	_	_	_	_
9	.	_	_	.	_	_	_	_	_


1	Frailty	_	_	NN	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	said	_	_	VBN	_	_	_	_	_
4	to	_	_	TO	_	_	_	_	_
5	be	_	_	VB	_	_	_	_	_
6	reversible	_	_	JJ	_	_	_	_	_
7	.	_	_	.	_	_	_	_	_


1	Therefore	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	it	_	_	PRP	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	expected	_	_	VBN	_	_	_	_	_
6	that	_	_	IN	_	_	_	_	_
7	appropriate	_	_	JJ	_	_	_	_	_
8	intervention	_	_	NN	_	_	_	_	_
9	for	_	_	IN	_	_	_	_	_
10	frail	_	_	JJ	_	_	_	_	_
11	older	_	_	JJR	_	_	_	_	_
12	adults	_	_	NNS	_	_	_	_	_
13	will	_	_	MD	_	_	_	_	_
14	lead	_	_	VB	_	_	_	_	_
15	to	_	_	TO	_	_	_	_	_
16	improvements	_	_	NNS	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	physical	_	_	JJ	_	_	_	_	_
19	function	_	_	NN	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	daily	_	_	JJ	_	_	_	_	_
22	living	_	_	NN	_	_	_	_	_
23	capabilities	_	_	NNS	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	help	_	_	VB	_	_	_	_	_
26	reverse	_	_	VB	_	_	_	_	_
27	frailty	_	_	NN	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	and	_	_	CC	_	_	_	_	_
30	prevent	_	_	VB	_	_	_	_	_
31	the	_	_	DT	_	_	_	_	_
32	onset	_	_	NN	_	_	_	_	_
33	of	_	_	IN	_	_	_	_	_
34	functional	_	_	JJ	_	_	_	_	_
35	disorders	_	_	NNS	_	_	_	_	_
36	.	_	_	.	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	prevention	_	_	NN	_	_	_	_	_
3	and	_	_	CC	_	_	_	_	_
4	improvement	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	frailty	_	_	NN	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	key	_	_	JJ	_	_	_	_	_
10	points	_	_	NNS	_	_	_	_	_
11	will	_	_	MD	_	_	_	_	_
12	be	_	_	VB	_	_	_	_	_
13	active	_	_	JJ	_	_	_	_	_
14	promotion	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	early	_	_	JJ	_	_	_	_	_
17	identification	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	risk	_	_	NN	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	desirable	_	_	JJ	_	_	_	_	_
22	interventions	_	_	NNS	_	_	_	_	_
23	as	_	_	IN	_	_	_	_	_
24	early	_	_	JJ	_	_	_	_	_
25	measures	_	_	NNS	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	“	_	_	``	_	_	_	_	_
2	Sarcopenia	_	_	NNP	_	_	_	_	_
3	”	_	_	''	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	coined	_	_	VBN	_	_	_	_	_
7	word	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	where	_	_	WRB	_	_	_	_	_
10	“	_	_	``	_	_	_	_	_
11	sarx	_	_	FW	_	_	_	_	_
12	(	_	_	-LRB-	_	_	_	_	_
13	sarco	_	_	FW	_	_	_	_	_
14	)	_	_	-RRB-	_	_	_	_	_
15	”	_	_	''	_	_	_	_	_
16	means	_	_	VBZ	_	_	_	_	_
17	muscle	_	_	NN	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	“	_	_	``	_	_	_	_	_
20	penia	_	_	NN	_	_	_	_	_
21	”	_	_	''	_	_	_	_	_
22	means	_	_	VBZ	_	_	_	_	_
23	“	_	_	``	_	_	_	_	_
24	loss	_	_	NN	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	reduction	_	_	NN	_	_	_	_	_
27	”	_	_	''	_	_	_	_	_
28	in	_	_	IN	_	_	_	_	_
29	Greek	_	_	NNP	_	_	_	_	_
30	,	_	_	,	_	_	_	_	_
31	and	_	_	CC	_	_	_	_	_
32	it	_	_	PRP	_	_	_	_	_
33	was	_	_	VBD	_	_	_	_	_
34	first	_	_	RB	_	_	_	_	_
35	proposed	_	_	VBN	_	_	_	_	_
36	by	_	_	IN	_	_	_	_	_
37	Rosenberg	_	_	NNP	_	_	_	_	_
38	in	_	_	IN	_	_	_	_	_
39	1989	_	_	CD	_	_	_	_	_
40	.	_	_	.	_	_	_	_	_


1	Originally	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	it	_	_	PRP	_	_	_	_	_
4	had	_	_	VBD	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	strong	_	_	JJ	_	_	_	_	_
7	physiological	_	_	JJ	_	_	_	_	_
8	nuance	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	decrease	_	_	NN	_	_	_	_	_
11	(	_	_	-LRB-	_	_	_	_	_
12	atrophy	_	_	NN	_	_	_	_	_
13	)	_	_	-RRB-	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	muscle	_	_	NN	_	_	_	_	_
16	mass	_	_	NN	_	_	_	_	_
17	with	_	_	IN	_	_	_	_	_
18	aging	_	_	NN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	in	_	_	IN	_	_	_	_	_
4	addition	_	_	NN	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	primary	_	_	JJ	_	_	_	_	_
7	(	_	_	-LRB-	_	_	_	_	_
8	aging	_	_	NN	_	_	_	_	_
9	)	_	_	-RRB-	_	_	_	_	_
10	sarcopenia	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	a	_	_	DT	_	_	_	_	_
13	broader	_	_	JJR	_	_	_	_	_
14	definition	_	_	NN	_	_	_	_	_
15	is	_	_	VBZ	_	_	_	_	_
16	taking	_	_	VBG	_	_	_	_	_
17	hold	_	_	NN	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	which	_	_	WDT	_	_	_	_	_
20	includes	_	_	VBZ	_	_	_	_	_
21	as	_	_	IN	_	_	_	_	_
22	secondary	_	_	JJ	_	_	_	_	_
23	sarcopenia	_	_	NN	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	reduction	_	_	NN	_	_	_	_	_
26	in	_	_	IN	_	_	_	_	_
27	muscle	_	_	NN	_	_	_	_	_
28	mass	_	_	NN	_	_	_	_	_
29	and	_	_	CC	_	_	_	_	_
30	muscle	_	_	NN	_	_	_	_	_
31	strength	_	_	NN	_	_	_	_	_
32	and	_	_	CC	_	_	_	_	_
33	further	_	_	JJR	_	_	_	_	_
34	muscle	_	_	NN	_	_	_	_	_
35	function	_	_	NN	_	_	_	_	_
36	loss	_	_	NN	_	_	_	_	_
37	,	_	_	,	_	_	_	_	_
38	due	_	_	JJ	_	_	_	_	_
39	to	_	_	TO	_	_	_	_	_
40	factors	_	_	NNS	_	_	_	_	_
41	associated	_	_	VBN	_	_	_	_	_
42	with	_	_	IN	_	_	_	_	_
43	activity	_	_	NN	_	_	_	_	_
44	,	_	_	,	_	_	_	_	_
45	disease	_	_	NN	_	_	_	_	_
46	,	_	_	,	_	_	_	_	_
47	and	_	_	CC	_	_	_	_	_
48	nutrition	_	_	NN	_	_	_	_	_
49	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	2016	_	_	CD	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	sarcopenia	_	_	NN	_	_	_	_	_
5	was	_	_	VBD	_	_	_	_	_
6	registered	_	_	VBN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	International	_	_	NNP	_	_	_	_	_
10	Classification	_	_	NNP	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	Diseases	_	_	NNPS	_	_	_	_	_
13	(	_	_	-LRB-	_	_	_	_	_
14	ICD-10	_	_	NNP	_	_	_	_	_
15	)	_	_	-RRB-	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	now	_	_	RB	_	_	_	_	_
4	considered	_	_	VBN	_	_	_	_	_
5	as	_	_	IN	_	_	_	_	_
6	a	_	_	DT	_	_	_	_	_
7	disease	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	measures	_	_	NNS	_	_	_	_	_
11	for	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	prevention	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	treatment	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	improvement	_	_	NN	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	sarcopenia	_	_	NN	_	_	_	_	_
21	are	_	_	VBP	_	_	_	_	_
22	urgently	_	_	RB	_	_	_	_	_
23	needed	_	_	VBN	_	_	_	_	_
24	in	_	_	IN	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	future	_	_	NN	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	has	_	_	VBZ	_	_	_	_	_
3	been	_	_	VBN	_	_	_	_	_
4	reported	_	_	VBN	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	frail	_	_	JJ	_	_	_	_	_
8	older	_	_	JJR	_	_	_	_	_
9	adults	_	_	NNS	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	exercise	_	_	NN	_	_	_	_	_
12	intervention	_	_	NN	_	_	_	_	_
13	is	_	_	VBZ	_	_	_	_	_
14	effective	_	_	JJ	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	improving	_	_	VBG	_	_	_	_	_
17	physical	_	_	JJ	_	_	_	_	_
18	functions	_	_	NNS	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	including	_	_	VBG	_	_	_	_	_
21	gait	_	_	NN	_	_	_	_	_
22	speed	_	_	NN	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	effects	_	_	NNS	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	recommended	_	_	VBN	_	_	_	_	_
8	specific	_	_	JJ	_	_	_	_	_
9	event	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	frequency	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	time	_	_	NN	_	_	_	_	_
15	have	_	_	VBP	_	_	_	_	_
16	not	_	_	RB	_	_	_	_	_
17	been	_	_	VBN	_	_	_	_	_
18	clarified	_	_	VBN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	addition	_	_	NN	_	_	_	_	_
3	to	_	_	TO	_	_	_	_	_
4	strength	_	_	NN	_	_	_	_	_
5	training	_	_	NN	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	multifaceted	_	_	JJ	_	_	_	_	_
8	exercise	_	_	NN	_	_	_	_	_
9	programs	_	_	NNS	_	_	_	_	_
10	that	_	_	WDT	_	_	_	_	_
11	incorporate	_	_	VBP	_	_	_	_	_
12	flexible	_	_	JJ	_	_	_	_	_
13	exercise	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	balance	_	_	NN	_	_	_	_	_
16	exercise	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	aerobic	_	_	JJ	_	_	_	_	_
20	exercise	_	_	NN	_	_	_	_	_
21	have	_	_	VBP	_	_	_	_	_
22	also	_	_	RB	_	_	_	_	_
23	been	_	_	VBN	_	_	_	_	_
24	reported	_	_	VBN	_	_	_	_	_
25	to	_	_	TO	_	_	_	_	_
26	improve	_	_	VB	_	_	_	_	_
27	muscle	_	_	NN	_	_	_	_	_
28	strength	_	_	NN	_	_	_	_	_
29	in	_	_	IN	_	_	_	_	_
30	frail	_	_	JJ	_	_	_	_	_
31	older	_	_	JJR	_	_	_	_	_
32	adults	_	_	NNS	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	has	_	_	VBZ	_	_	_	_	_
3	been	_	_	VBN	_	_	_	_	_
4	suggested	_	_	VBN	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	interventions	_	_	NNS	_	_	_	_	_
7	focused	_	_	VBN	_	_	_	_	_
8	on	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	physical	_	_	JJ	_	_	_	_	_
11	elements	_	_	NNS	_	_	_	_	_
12	behind	_	_	IN	_	_	_	_	_
13	frailty	_	_	NN	_	_	_	_	_
14	(	_	_	-LRB-	_	_	_	_	_
15	weight	_	_	NN	_	_	_	_	_
16	loss	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	muscle	_	_	NN	_	_	_	_	_
19	weakness	_	_	NN	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	exhaustion	_	_	NN	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	slowness	_	_	NN	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	low	_	_	JJ	_	_	_	_	_
26	physical	_	_	JJ	_	_	_	_	_
27	activity	_	_	NN	_	_	_	_	_
28	)	_	_	-RRB-	_	_	_	_	_
29	are	_	_	VBP	_	_	_	_	_
30	effective	_	_	JJ	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	and	_	_	CC	_	_	_	_	_
33	comprehensive	_	_	JJ	_	_	_	_	_
34	interventions	_	_	NNS	_	_	_	_	_
35	incorporating	_	_	VBG	_	_	_	_	_
36	as	_	_	IN	_	_	_	_	_
37	many	_	_	JJ	_	_	_	_	_
38	of	_	_	IN	_	_	_	_	_
39	the	_	_	DT	_	_	_	_	_
40	elements	_	_	NNS	_	_	_	_	_
41	as	_	_	IN	_	_	_	_	_
42	possible	_	_	JJ	_	_	_	_	_
43	are	_	_	VBP	_	_	_	_	_
44	desirable	_	_	JJ	_	_	_	_	_
45	.	_	_	.	_	_	_	_	_


1	Resistance	_	_	NN	_	_	_	_	_
2	training	_	_	NN	_	_	_	_	_
3	and	_	_	CC	_	_	_	_	_
4	nutritional	_	_	JJ	_	_	_	_	_
5	(	_	_	-LRB-	_	_	_	_	_
6	protein	_	_	NN	_	_	_	_	_
7	)	_	_	-RRB-	_	_	_	_	_
8	interventions	_	_	NNS	_	_	_	_	_
9	are	_	_	VBP	_	_	_	_	_
10	often	_	_	RB	_	_	_	_	_
11	selected	_	_	VBN	_	_	_	_	_
12	as	_	_	IN	_	_	_	_	_
13	measures	_	_	NNS	_	_	_	_	_
14	for	_	_	IN	_	_	_	_	_
15	prevention	_	_	NN	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	improvement	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	sarcopenia	_	_	NN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	a	_	_	DT	_	_	_	_	_
3	report	_	_	NN	_	_	_	_	_
4	on	_	_	IN	_	_	_	_	_
5	increased	_	_	VBN	_	_	_	_	_
6	muscle	_	_	NN	_	_	_	_	_
7	mass	_	_	NN	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	muscle	_	_	NN	_	_	_	_	_
10	strength	_	_	NN	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	older	_	_	JJR	_	_	_	_	_
13	adults	_	_	NNS	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	a	_	_	DT	_	_	_	_	_
16	high	_	_	JJ	_	_	_	_	_
17	load	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	70	_	_	CD	_	_	_	_	_
20	–	_	_	TO	_	_	_	_	_
21	80	_	_	CD	_	_	_	_	_
22	%	_	_	NN	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	1	_	_	CD	_	_	_	_	_
25	repetition	_	_	NN	_	_	_	_	_
26	maximum	_	_	NN	_	_	_	_	_
27	(	_	_	-LRB-	_	_	_	_	_
28	RM	_	_	NN	_	_	_	_	_
29	)	_	_	-RRB-	_	_	_	_	_
30	was	_	_	VBD	_	_	_	_	_
31	used	_	_	VBN	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	for	_	_	IN	_	_	_	_	_
4	older	_	_	JJR	_	_	_	_	_
5	adults	_	_	NNS	_	_	_	_	_
6	without	_	_	IN	_	_	_	_	_
7	exercise	_	_	NN	_	_	_	_	_
8	habits	_	_	NNS	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	it	_	_	PRP	_	_	_	_	_
11	was	_	_	VBD	_	_	_	_	_
12	reported	_	_	VBN	_	_	_	_	_
13	that	_	_	IN	_	_	_	_	_
14	even	_	_	RB	_	_	_	_	_
15	with	_	_	IN	_	_	_	_	_
16	a	_	_	DT	_	_	_	_	_
17	load	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	40	_	_	CD	_	_	_	_	_
20	–	_	_	TO	_	_	_	_	_
21	50	_	_	CD	_	_	_	_	_
22	%	_	_	NN	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	1	_	_	CD	_	_	_	_	_
25	RM	_	_	NN	_	_	_	_	_
26	improvement	_	_	NN	_	_	_	_	_
27	in	_	_	IN	_	_	_	_	_
28	muscle	_	_	NN	_	_	_	_	_
29	function	_	_	NN	_	_	_	_	_
30	can	_	_	MD	_	_	_	_	_
31	be	_	_	VB	_	_	_	_	_
32	expected	_	_	VBN	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	When	_	_	WRB	_	_	_	_	_
2	setting	_	_	VBG	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	low	_	_	JJ	_	_	_	_	_
5	load	_	_	NN	_	_	_	_	_
6	cannot	_	_	MD	_	_	_	_	_
7	be	_	_	VB	_	_	_	_	_
8	avoided	_	_	VBN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	long-term	_	_	JJ	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	high	_	_	JJ	_	_	_	_	_
13	frequency	_	_	NN	_	_	_	_	_
14	interventions	_	_	NNS	_	_	_	_	_
15	may	_	_	MD	_	_	_	_	_
16	be	_	_	VB	_	_	_	_	_
17	necessary	_	_	JJ	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	Moreover	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	nutritional	_	_	JJ	_	_	_	_	_
4	interventions	_	_	NNS	_	_	_	_	_
5	for	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	purpose	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	promoting	_	_	VBG	_	_	_	_	_
10	muscle	_	_	NN	_	_	_	_	_
11	protein	_	_	NN	_	_	_	_	_
12	synthesis	_	_	NN	_	_	_	_	_
13	(	_	_	-LRB-	_	_	_	_	_
14	such	_	_	JJ	_	_	_	_	_
15	as	_	_	IN	_	_	_	_	_
16	amino	_	_	JJ	_	_	_	_	_
17	acid	_	_	NN	_	_	_	_	_
18	intake	_	_	NN	_	_	_	_	_
19	)	_	_	-RRB-	_	_	_	_	_
20	are	_	_	VBP	_	_	_	_	_
21	effective	_	_	JJ	_	_	_	_	_
22	in	_	_	IN	_	_	_	_	_
23	increasing	_	_	VBG	_	_	_	_	_
24	muscle	_	_	NN	_	_	_	_	_
25	mass	_	_	NN	_	_	_	_	_
26	and	_	_	CC	_	_	_	_	_
27	improving	_	_	VBG	_	_	_	_	_
28	muscle	_	_	NN	_	_	_	_	_
29	strength	_	_	NN	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	Accordingly	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	not	_	_	RB	_	_	_	_	_
4	only	_	_	RB	_	_	_	_	_
5	exercise	_	_	NN	_	_	_	_	_
6	interventions	_	_	NNS	_	_	_	_	_
7	but	_	_	CC	_	_	_	_	_
8	also	_	_	RB	_	_	_	_	_
9	nutritional	_	_	JJ	_	_	_	_	_
10	interventions	_	_	NNS	_	_	_	_	_
11	undertaken	_	_	VBN	_	_	_	_	_
12	concurrently	_	_	RB	_	_	_	_	_
13	are	_	_	VBP	_	_	_	_	_
14	expected	_	_	VBN	_	_	_	_	_
15	to	_	_	TO	_	_	_	_	_
16	be	_	_	VB	_	_	_	_	_
17	effective	_	_	JJ	_	_	_	_	_
18	against	_	_	IN	_	_	_	_	_
19	sarcopenia	_	_	NN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_

